Randy Prescilla

1.5k total citations · 1 hit paper
37 papers, 1.0k citations indexed

About

Randy Prescilla is a scholar working on Dermatology, Immunology and Allergy and Physiology. According to data from OpenAlex, Randy Prescilla has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Dermatology, 18 papers in Immunology and Allergy and 12 papers in Physiology. Recurrent topics in Randy Prescilla's work include Dermatology and Skin Diseases (22 papers), Allergic Rhinitis and Sensitization (12 papers) and Asthma and respiratory diseases (12 papers). Randy Prescilla is often cited by papers focused on Dermatology and Skin Diseases (22 papers), Allergic Rhinitis and Sensitization (12 papers) and Asthma and respiratory diseases (12 papers). Randy Prescilla collaborates with scholars based in United States, Germany and United Kingdom. Randy Prescilla's co-authors include David Zurakowski, Keira P. Mason, Paulette J. Fontaine, Steven E. Zgleszewski, Eric L. Simpson, Susan M. Goobie, Petra M. Meier, Sulpicio G. Soriano, Luis M. Pereira and John G. Meara and has published in prestigious journals such as Radiology, Journal of Allergy and Clinical Immunology and Anesthesiology.

In The Last Decade

Randy Prescilla

35 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study

2018 250 citations Emma Guttman‐Yassky, Jonathan I. Silverberg et al. Journal of the American Academy of Dermatology profile →

Peers

Randy Prescilla

DERMA

APM

CCICM

X. D. Wang China

Koung‐Shing Chu Taiwan

U. G. Svendsen Denmark

H. E. Eliahou Israel

R. S. Jones United Kingdom

Alvaro A. Macias United States

Aslıhan Karul Türkiye

Brian M. Morrissey United States

G J Beckett United Kingdom

David H. Jang United States

X. D. Wang China

Randy Prescilla

111 ×0.4

DERMA

16 ×0.1

APM

262 ×1.1

33 ×0.2

64 ×0.3

CCICM

Citations per year, relative to Randy Prescilla Randy Prescilla (= 1×) peers X. D. Wang

Countries citing papers authored by Randy Prescilla

Since Specialization

Citations

This map shows the geographic impact of Randy Prescilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randy Prescilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randy Prescilla more than expected).

Fields of papers citing papers by Randy Prescilla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randy Prescilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randy Prescilla. The network helps show where Randy Prescilla may publish in the future.

Co-authorship network of co-authors of Randy Prescilla

This figure shows the co-authorship network connecting the top 25 collaborators of Randy Prescilla. A scholar is included among the top collaborators of Randy Prescilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randy Prescilla. Randy Prescilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Siegfried, Elaine C., Lara Wine Lee, Jonathan M. Spergel, et al.. (2024). A case series of live attenuated vaccine administration in dupilumab‐treated children with atopic dermatitis. Pediatric Dermatology. 41(2). 204–209. 9 indexed citations

Paller, Amy S., Jonathan I. Silverberg, Eric L. Simpson, et al.. (2024). The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: Results from a placebo-controlled, phase 3 study. Journal of the American Academy of Dermatology. 92(1). 116–126. 4 indexed citations

Paller, Amy S., Mercedes E. González, Lynda C. Schneider, et al.. (2024). Dupilumab treatment reduces caregiver-reported skin pain in patients with moderate-to-severe atopic dermatitis aged 6 months to 5 years. Frontiers in Pediatrics. 12. 1446779–1446779. 1 indexed citations

Siegfried, Elaine C., Eric L. Simpson, Michael J. Cork, et al.. (2023). Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years. Dermatology and Therapy. 13(9). 1987–2000. 3 indexed citations

Cork, Michael J., Diamant Thaçi, Lawrence F. Eichenfield, et al.. (2023). Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis. Dermatology and Therapy. 13(11). 2697–2719. 16 indexed citations

Paller, Amy S., Eric L. Simpson, Elaine C. Siegfried, et al.. (2023). 41817 Dupilumab Treatment Improves Sleep Quality in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis and Their Caregivers. Journal of the American Academy of Dermatology. 89(3). AB40–AB40. 1 indexed citations

Paller, Amy S., Elaine C. Siegfried, Michael J. Cork, et al.. (2022). Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis. Pediatric Drugs. 25(1). 67–77. 4 indexed citations

Siegfried, Elaine C., Thomas Bieber, Eric L. Simpson, et al.. (2021). Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial. American Journal of Clinical Dermatology. 22(2). 243–255. 18 indexed citations

Simpson, Eric L., Marjolein de Bruin‐Weller, Ashish Bansal, et al.. (2021). Definition of Clinically Meaningful Within-Patient Changes in POEM and CDLQI in Children 6 to 11 Years of Age with Severe Atopic Dermatitis. Dermatology and Therapy. 11(4). 1415–1422. 15 indexed citations

10.

Mason, Keira P., et al.. (2020). The synergistic effect of dexmedetomidine on propofol for paediatric deep sedation. European Journal of Anaesthesiology. 38(5). 541–547. 13 indexed citations

11.

Guttman‐Yassky, Emma, Jonathan I. Silverberg, Osamu Nemoto, et al.. (2018). Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study. Journal of the American Academy of Dermatology. 80(4). 913–921.e9. 250 indexed citations breakdown →

12.

Mason, Keira P., Randy Prescilla, James C. Root, et al.. (2016). Feasibility of measuring memory response to increasing dexmedetomidine sedation in children. British Journal of Anaesthesia. 118(2). 254–263. 4 indexed citations

13.

Prescilla, Randy & Keira P. Mason. (2014). Recent advances and contributions to procedural sedation with considerations for the future.. PubMed. 80(7). 844–55. 6 indexed citations

14.

Mason, Keira P., Fay Robinson, Paulette J. Fontaine, & Randy Prescilla. (2013). Dexmedetomidine Offers an Option for Safe and Effective Sedation for Nuclear Medicine Imaging in Children. Radiology. 267(3). 911–917. 46 indexed citations

15.

Goobie, Susan M., Petra M. Meier, Luis M. Pereira, et al.. (2011). Efficacy of Tranexamic Acid in Pediatric Craniosynostosis Surgery. Anesthesiology. 114(4). 862–871. 208 indexed citations

16.

Mason, Keira P., David Zurakowski, Steven E. Zgleszewski, et al.. (2010). Incidence and predictors of hypertension during high-dose dexmedetomidine sedation for pediatric MRI. Pediatric Anesthesia. 20(6). 516–523. 75 indexed citations

17.

Mason, Keira P., Steven E. Zgleszewski, Randy Prescilla, Paulette J. Fontaine, & David Zurakowski. (2008). Hemodynamic effects of dexmedetomidine sedation for CT imaging studies. Pediatric Anesthesia. 18(5). 393–402. 96 indexed citations

18.

Prescilla, Randy, et al.. (2004). Pharmacokinetics of Rofecoxib in Children With Sickle Cell Hemoglobinopathy. Journal of Pediatric Hematology/Oncology. 26(10). 661–664. 3 indexed citations

19.

Prescilla, Randy, et al.. (2003). Influence of Goldenseal Root on the Pharmacokinetics of Indinavir. The Journal of Clinical Pharmacology. 43(11). 1283–1288. 37 indexed citations

20.

Ostrea, Enrique M., et al.. (2002). Prevalence of Fetal Exposure to Environmental Toxins as Determined by Meconium Analysis. NeuroToxicology. 23(3). 329–339. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact